Overbrook Management Corp’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $228K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $232K | Hold |
|
|||||
|
2024
Q2 | $253K | Sell |
|
|||||
|
2024
Q1 | $298K | Sell |
|
|||||
|
2023
Q4 | $303K | Hold |
|
|||||
|
2023
Q3 | $210K | Sell |
|
|||||
|
2023
Q2 | $263K | Hold |
|
|||||
|
2023
Q1 | $279K | Sell |
|
|||||
|
2022
Q4 | $360K | Hold |
|
|||||
|
2022
Q3 | $227K | Sell |
|
|||||
|
2022
Q2 | $222K | Hold |
|
|||||
|
2022
Q1 | $281K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $10K | Hold |
|
|||||
|
2018
Q3 | $22K | Hold |
|
|||||
|
2018
Q2 | $24K | Hold |
|
|||||
|
2018
Q1 | $113K | Hold |
|
|||||
|
2017
Q4 | $138K | Hold |
|
|||||
|
2017
Q3 | $139K | Sell |
|
|||||
|
2017
Q2 | $139K | Buy |
|